Pancreatic Cancer Clinical Trials in Scottsdale, Arizona

6 studies are recruiting for pancreatic cancer in Scottsdale, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

   The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   HonorHealth Research Institute, Scottsdale, Arizona

   Locations

   74 in total

   Run by

   Revolution Medicines, Inc.

   See if you can join NCT07252232 on ClinicalTrials.gov

2. Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

   The purpose of this study is to evaluate the safety and efficacy of an investigational RAS(ON) inhibitor administered as monotherapy or in combination with chemotherapy, compared with standard of care (SOC) chemotherapy alone.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Honor Health Research Institute, Scottsdale, Arizona

   Locations

   49 in total

   Run by

   Revolution Medicines, Inc.

   See if you can join NCT07491445 on ClinicalTrials.gov

3. Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

   This is a multi-center clinical study enrolling up to 50 participants. The primary objective of the study is to evaluate the safety of Alpha DaRT in combination with chemotherapy, based on the cumulative incidence rate, severity and outcome of device related AEs. Classification of AEs will be done …

   Stage

   Not phased

   Ages

   18 to 120

   Site

   Honor Health, Scottsdale, Arizona

   Locations

   15 in total

   Run by

   Alpha Tau Medical LTD.

   See if you can join NCT06698458 on ClinicalTrials.gov

4. AOH1996 for the Treatment of Refractory Solid Tumors

   This phase I trial studies the side effects and best dose of AOH1996 in treating patients with solid tumors that do not respond to treatment (refractory). AOH1996 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Honor Health Research and Innovation Institute, Scottsdale, Arizona

   Locations

   3 in total

   Run by

   City of Hope Medical Center

   See if you can join NCT05227326 on ClinicalTrials.gov

5. Pancreatic Cancer Detection Consortium

   This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Honorhealth, Scottsdale, Arizona

   Locations

   11 in total

   Run by

   City of Hope Medical Center

   See if you can join NCT06388967 on ClinicalTrials.gov

6. PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

   This is an open-label, phase II study in patients with resectable and borderline resectable pancreatic cancer.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   HonorHealth Medical Group, Scottsdale, Arizona

   Locations

   2 in total

   Run by

   Medical College of Wisconsin

   See if you can join NCT04683315 on ClinicalTrials.gov